Capula Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Sell
1,600
-400
-20% -$35.6K ﹤0.01% 832
2025
Q4
$158K Buy
2,000
+600
+43% +$47K ﹤0.01% 638
2025
Q3
$112K Sell
1,400
-900
-39% -$76.8K ﹤0.01% 709
2025
Q2
$209K Sell
2,300
-300
-12% -$27.4K ﹤0.01% 367
2025
Q1
$244K Buy
+2,600
New +$233K ﹤0.01% 469
2021
Q4
Sell
-106,900
Closed -$8.03M 291
2021
Q3
$8.03M Buy
106,900
+20,600
+24% +$1.64M 0.1% 171
2021
Q2
$6.98M Buy
+86,300
New +$7.06M 0.11% 156
2020
Q3
Sell
-15,000
Closed -$1.1M 164
2020
Q2
$1.1M Buy
+15,000
New +$1.07M 0.04% 243

Other funds holding CL

Capula Management's CL Position: Q1 2026 in Review

Capula Management reduced its Colgate-Palmolive (CL) stake by 94% in Q1 2026, selling an estimated $368K and leaving 243 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1041.

Capula Management first reported a position in CL in Q4 2019 and has held it in 10 quarters since. The position peaked at $4.6M in Q3 2021. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Capula Management held 243 shares of Colgate-Palmolive worth $20.7K as of Q1 2026.
  • Capula Management sold 4,133 Colgate-Palmolive shares in Q1 2026, an estimated $368K.
  • Colgate-Palmolive made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #1041 holding.
  • Capula Management first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 10 quarters since.
  • Capula Management's Colgate-Palmolive position peaked at $4.6M in Q3 2021.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.